Alliqua Biomedical Announces Expansion to Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
06 oct. 2014 07h30 HE
|
Adynxx, Inc.
Amendment Expands Field of Use for Biovance® to Include Podiatric and Orthopedic Applications
LANGHORNE, Pa., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Alliqua Biomedical, Inc. (Nasdaq:ALQA)...
Alliqua BioMedical to Present at Upcoming Investor Conferences
02 sept. 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), today announced that Company management will participate in the following...
Alliqua Biomedical, Inc. Reports Second Quarter 2014 Financial Results
11 août 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Alliqua Biomedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced financial results for...
Alliqua BioMedical Announces Changes to Its Board of Directors
22 juil. 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), today announced the appointment of Andrew Africk and Gary Restani to its Board of...
Alliqua BioMedical's CEO Issues Midyear Corporate Update for Shareholders
10 juil. 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., July 10, 2014 (GLOBE NEWSWIRE) -- David Johnson, Chief Executive Officer of Alliqua Biomedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), has issued the following letter to...
Alliqua BioMedical Added to the Russell Microcap(R) Index
30 juin 2014 12h15 HE
|
Adynxx, Inc.
LANGHORNE, Pa., June 30, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, was added to the U.S. Russell...
Alliqua Reincorporates in State of Delaware, De-Staggers Board and Changes Name to Alliqua BioMedical
11 juin 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., June 11, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, announced that its shareholders...
Alliqua Reports First Quarter 2014 Financial Results
12 mai 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced financial results for the first...
Alliqua Acquires Choice Therapeutics
06 mai 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., May 6, 2014 (GLOBE NEWSWIRE) -- Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company"), a provider of advanced wound care products, has acquired Choice Therapeutics, Inc. ("Choice...
Alliqua to Launch Biovance(R) Human Amniotic Membrane Allograft Product Licensed From Celgene
23 avr. 2014 07h30 HE
|
Adynxx, Inc.
LANGHORNE, Pa., April 23, 2014 (GLOBE NEWSWIRE) -- Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, will launch its Biovance® human amniotic...